| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Revenue | $390.7M | +37.2% |
| Cost of Revenue | $159.4M | +41.7% |
| Gross Profit | $231.3M | +34.2% |
| R&D Expense | $238.5M | +5.5% |
| SG&A Expense | $75.3M | +3.4% |
| Operating Income | -$82.5M | +34.8% |
| Pre-tax Income | -$73.7M | +37.4% |
| Income Tax | $2.2M | +460.1% |
| Net Income | -$75.9M | +35.2% |
| EPS (Basic) | -$1.78 | +37.3% |
| EPS (Diluted) | -$1.78 | +37.3% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $191.0M | +32.1% |
| Accounts Receivable | $39.2M | +31.6% |
| Inventory | $52.2M | +51.8% |
| Current Assets | $410.3M | +28.0% |
| Total Assets | $798.6M | +15.9% |
| Current Liabilities | $177.9M | +47.1% |
| Total Liabilities | $203.8M | +59.8% |
| Stockholders' Equity |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $73.5M | +117.3% |
| Investing Cash Flow | -$30.5M | +24.8% |
| Financing Cash Flow | $3.8M | -40.5% |
| $594.8M |
| +5.9% |